CNS Infections

Routes of Entry and Causative Agents of Bacterial and Viral Meningitis

• Definition and Anatomical Localization:

  • Meningitis is an infectious inflammatory process involving the meninges coating the outer brain and spinal cord, localized primarily within the subarachnoid space where cerebrospinal fluid (CSF) circulates.

  • Encephalitis refers specifically to an infection residing within the parenchyma of the brain tissue itself.

• Routes of Bacterial Entry into the Central Nervous System (CNS):

  • Hematogenous Spread (Bloodstream): Systemic bacteremia or septicemia spreads hematogenously across the blood-brain barrier to seed the meninges.

  • Direct Contiguity / Extension from Adjacent Structures: Chronic or acute otitis media and sinusitis. Pathogens seed upward directly through the base of the skull into the dura mater and meningeal layers overlying the sinuses.

  • Direct Inoculation / Trauma: Penetrating trauma or neurosurgical disruptions, such as a craniotomy or ventriculostomy placement.

  • Direct Neuronal Extension: Retrograde movement along cranial nerves (e.g., rabies transmission).

  • Droplet Transmission via Mucous Membranes: Inhalation of mouth or nose respiratory droplets carrying specific virulent bacteria.

• Causative Organisms:

  • Bacterial Pathogens:

    • Haemophilus influenzae (droplet-spread). More prevalent in children

    • Neisseria meningitidis (meningococcal meningitis; droplet-spread, highly contagious in crowded living conditions such as college dormitories and military barracks, capable of causing localized epidemics).

    • Streptococcus species.

    • Listeria monocytogenes.

    • Streptococcus pneumoniae (pneumococcal meningitis; patients post-splenectomy carry a significantly elevated risk).

  • Viral Pathogens: Various viral agents producing enteroviral or lymphocytic meningitis.

  • Fungal Pathogens: High incidence in immunocompromised hosts, particularly individuals with HIV/AIDS presenting with opportunistic fungal infections.

Pathophysiology and Clinical Manifestations of Meningitis

• Pathophysiology of Bacterial Meningitis:

  • Pathogens enter the subarachnoid space and multiply within the CSF.

  • The immune response triggers localized recruitment of white blood cells, specifically neutrophils or polymorphonuclear leukocytes (PMNs).

  • Neutrophils aggregate and clump together in large quantities, producing thick, purulent exudate (pus) within the subarachnoid space.

  • Development of Hydrocephalus: Normal CSF reabsorption occurs via the arachnoid villi into the dural venous sinuses. The thick purulent drainage physically clogs the arachnoid villi, preventing CSF clearance and resulting in structural hydrocephalus.

  • Development of Cerebral Edema and Increased ICP: Aggregated neutrophils undergo cellular degradation and lysis, releasing toxic inflammatory mediators, vasoconstrictive substances, and cellular enzymes. This cascade disrupts vascular permeability, causing prominent vasogenic cerebral edema (and secondarily cytotoxic cerebral edema), driving severe elevations in intracranial pressure (ICP).

• Pathophysiology of Viral Meningitis:

  • The predominant white blood cells recruited are lymphocytes rather than neutrophils.

  • Lymphocytes do not form thick purulent exudate and do not release destructive necrotizing toxins or severe vasoconstrictive mediators.

  • As a result, viral meningitis does not trigger severe arachnoid villi occlusion or major vasogenic swelling, making it benign relative to bacterial meningitis, with significantly lower morbidity and mortality rates.

• Adult Clinical Presentation:

  • Classic Triad: Headache, high fever, and nuchal rigidity.

  • Additional Signs and Symptoms: Photophobia, altered level of consciousness (LOC), cranial nerve palsies, and petechial or purpuric cutaneous hemorrhaging (pathognomonic for meningococcal meningitis).

  • Kernig's Sign: Evaluated with the patient supine. The hip and knee are flexed to a $90^\circ$ angle, followed by passive extension of the lower leg at the knee. A positive test produces intense hamstring pain and involuntary hamstring muscle spasms.

  • Brudzinski's Sign: Evaluated with the patient supine. The examiner passively flexes the patient's neck (chin to chest). A positive test induces spontaneous, involuntary flexion of the hips and knees.

• Pediatric Clinical Presentation:

  • Pediatric patients often cannot express or describe a headache.

  • Key signs include marked irritability, poor feeding or refusal to eat and drink, persistent vomiting, high-pitched crying (indicative of acute ICP elevation), fever, nuchal rigidity, and bulging fontanels (present in approximately $50\%$ of pediatric meningitis cases).

• Meningococcal Meningitis Specifics and Complications:

  • Caused by Neisseria meningitidis and transmitted via respiratory droplets in closed environments.

  • Triggers widespread cutaneous purpura and severe systemic vasculitis with small-vessel thrombosis.

  • Thrombus formation cuts off arterial perfusion to distal extremities, resulting in ischemic necrosis and subsequent surgical amputations of fingers, toes, hands, or entire limbs in surviving patients.

  • Vaccination offers preventive coverage against selected strains, though multiple non-covered serogroups exist. Immunization is routinely administered to military recruits and offered to college students living in dorms.

Diagnostic CSF Findings, Clinical Nuances, and Management

• Diagnostic Evaluation:

  • History and physical examination emphasizing infectious exposure, recent acute or chronic otitis media, sinusitis, or upper respiratory tract infections.

  • Non-contrast head CT scan: Performed prior to lumbar puncture (LP) in patients with altered level of consciousness or focal neurological deficits to rule out mass lesions, subarachnoid hemorrhage, or severe cerebral edema with impending brain herniation.

  • Lumbar puncture for definitive CSF analysis.

• Cerebrospinal Fluid (CSF) Analysis Comparison:

  • Bacterial Meningitis CSF Profile:

    • Gross Appearance: Turbid, cloudy, or purulent.

    • White Blood Cells: Markedly elevated with a heavy predominance of neutrophils and PMN leukocytes.

    • Protein: Significantly elevated, typically exceeding $150\,m\text{g/dL}$.

    • Glucose: Markedly decreased (bacteria actively consume glucose as a metabolic substrate).

    • Opening Pressure: Elevated.

    • Microbiology: Positive Gram stain and bacterial culture (negative cultures occur in up to $30\%$ of cases, termed aseptic meningitis).

    • Lactate: Elevated.

  • Viral Meningitis CSF Profile:

    • Gross Appearance: Clear or slightly turbid.

    • White Blood Cells: Elevated with a differential showing a predominant surge in lymphocytes (benign lymphocytic meningitis).

    • Protein: Elevated, but typically much lower than bacterial thresholds.

    • Glucose: Normal (viruses do not metabolize extracellular glucose).

    • Microbiology: Negative Gram stain and bacterial culture.

    • Lactate: Normal.

• Diagnostic Nuances and Limitations:

  • CSF-to-Serum Glucose Ratio: Normal CSF glucose is approximately two-thirds ($\frac{2}{3}$) or $\approx 66.7\%$ of the simultaneous serum glucose. CSF glucose values must always be interpreted in relation to serum glucose.

  • Equilibration Delay: Following administration of concentrated intravenous dextrose (such as $50\%$ dextrose / D50), it takes at least $2\text{ to }4\text{ hours}$ for CSF glucose levels to equilibrate to two-thirds of serum levels. Testing during this window creates a false discrepancy.

  • Severe Hyperglycemia: In patients with uncontrolled diabetes and serum glucose levels exceeding $300\,m\text{g/dL}$, CSF glucose ratios may appear falsely depressed.

  • Early Bacterial Phase: Early stages of bacterial meningitis can transiently demonstrate lymphocyte elevation before the major neutrophil surge occurs.

  • Traumatic Tap: Accidental vessel puncture during LP falsely elevates both red blood cell (RBC) and white blood cell counts in the sample.

• Contraindications to Lumbar Puncture:

  • Neonates with severe cardiovascular instability or compromise.

  • Altered level of consciousness with unruled-out high ICP (removing lumbar CSF creates a brainstem herniation hazard due to pressure differentials).

  • Localized skin infections, abscesses, or pustules overlying the spinal puncture site.

  • Concurrent anticoagulant therapy or antiplatelet administration (risk of epidural or subdural spinal hematoma leading to acute spinal cord compression).

• Medical and Surgical Management:

  • Antibiotic Therapy: Immediate initiation of broad-spectrum empirical intravenous antibiotics prior to exact culture identification improves clinical outcomes.

  • Supportive Therapy: Antipyretics (e.g., acetaminophen) for fever control; targeted analgesia for severe head and neck pain.

  • Corticosteroid Use: Dexamethasone administration significantly decreases long-term sensorineural hearing loss in pediatric patients; its routine efficacy in adults remains variable.

  • Surgical Intervention: Surgical evacuation of subdural empyemas; placement of ventriculoperitoneal (VP) or temporary external ventricular shunts for severe acute hydrocephalus; surgical excision or aspiration of encapsulated brain abscesses.

  • Complications: Arterial wall vasculitis leading to ischemic or hemorrhagic stroke, arterial wall fibrosis, acoustic nerve damage with total hearing loss, optic nerve damage, acute encephalitis, secondary brain abscess, chronic hydrocephalus, and post-meningitis sequelae (persistent tremors, chronic respiratory infections).

Pathophysiology, Presentation, and Management of Brain Abscesses

• Pathophysiology:

  • A brain abscess is an encapsulated focal mass of purulent drainage contained within central nervous system structures, harboring varying stages of tissue necrosis and active infection.

  • The fibrous capsule wall is frequently thin; spontaneous rupture releases purulent material directly into the ventricular system or brain parenchyma, causing catastrophic, widespread encephalitis.

  • Anatomical locations include intraparenchymal tissue, the subdural space, or the epidural space.

• Clinical Presentation:

  • Persistent severe headache, fever, and altered mental status.

  • New-onset focal or generalized seizures in patients with no prior history of seizure activity.

• Diagnostic Imaging:

  • Initial non-contrast CT shows a hypodense mass effect with midline shift or ventricular compression.

  • Contrast-enhanced CT or contrast MRI demonstrates a distinct, uniform ring-enhancing lesion with a wall thickness measuring approximately $1\text{ to }3\,m\text{m}$.

  • Imaging reveals prominent surrounding focal vasogenic cerebral edema.

  • Differential Imaging Diagnostic: Glioblastoma multiforme can also display ring enhancement, but presents with an irregular, non-uniform, incomplete ring structure.

• Therapeutic Interventions:

  • Targeted high-dose long-term intravenous antimicrobial administration.

  • Surgical evacuation of purulent contents: CT-guided stereotactic burr hole aspiration (preferred for superficial, subdural, or epidural lesions) or open craniotomy with surgical excision (indicated for deep intraparenchymal abscesses).

Prion Diseases: Mechanisms and Pathology

• Fundamental Nature of Prion Diseases:

  • Prion diseases are Transmissible Spongiform Encephalopathies (TSEs)—rare, neurodegenerative, invariably fatal conditions affecting humans and animals.

  • "Spongiform" refers to the microscopic formation of tiny clear vacuoles throughout brain tissue, imparting a sponge-like appearance on post-mortem histological examination.

  • The transmissible agent is a prion (proteinaceous infectious particle). It is completely devoid of nucleic acids (DNA/RNA) and is not a bacterium, virus, parasite, or fungus.

• Molecular Mechanism:

  • The host body naturally produces normal, harmless cellular prion proteins ($\text{PrP}^C$).

  • An infectious trigger or genetic mutation induces the normal protein to refold and enfold on itself into an abnormal, pathological, insoluble conformation ($\text{PrP}^{Sc}$).

  • Once formed, abnormal prions act as templates, forcing adjacent normal cellular proteins to misfold into the infectious conformation, accumulating in the central nervous system.

• Histological Triad of Prion Disease:

  1. Widespread spongiform vacuolization/cavitation within gray matter.

  2. Severe neuronal loss and profound brain tissue atrophy.

  3. Astroglial cell proliferation (reactive gliosis) accompanied by amyloid plaque deposition (microscopically similar to plaques observed in Alzheimer's disease).

• Systemic Dissemination:

  • Abnormal prions migrate to CNS tissues via extraneural and lymphatic pathways, colonizing lymphoid organs including the spleen, lymph nodes, and tonsils prior to neural invasion.

Human and Animal Prion Diseases: CJD, Variants, and Transmission

• Spectrum of Prion Diseases:

  • Human Forms: Creutzfeldt-Jakob Disease (CJD), Variant Creutzfeldt-Jakob Disease (vCJD), Kuru (historically transmitted among the Fore/Curio tribe via ritual cannibalistic consumption of human brain tissue).

  • Animal Forms: Bovine Spongiform Encephalopathy (BSE or "Mad Cow Disease" in cattle), Scrapie (in sheep), Chronic Wasting Disease (CWD in deer, elk, and moose).

• Classical Creutzfeldt-Jakob Disease (CJD):

  • Epidemiology: Affects approximately $1\text{ per }1,000,000$ people per year ($280\text{ to }300\text{ cases/year}$ in the United States).

  • Three Modes of Transmission:

    1. Sporadic CJD: Accounts for the majority of cases ($\approx 85\%$). Spontaneous, random unfolding of normal proteins into abnormal prions without clear cause; typically occurs in individuals over the age of $50\text{ years}$ and presents initially with cerebellar ataxia.

    2. Hereditary/Genetic CJD: Caused by an autosomal dominant gene mutation in the prion protein gene ($50\%$ chance of transmission to offspring). Symptoms typically manifest late in life (ages $50\text{ to }70\text{ years}$), allowing carriers to unknowingly pass the mutated gene to multiple generations before diagnosis.

    3. Iatrogenic/Transmitted CJD: Direct exposure to infected neural tissues, spinal fluid, dura mater grafts, corneal transplants, or contaminated neurosurgical hardware.

• Iatrogenic Hazards and Sterilization Resistance:

  • Prions are resistant to conventional sterilization techniques, including boiling, chemical disinfection, and standard autoclaving.

  • Standard neurosurgical instruments used on patients with undiagnosed CJD retain infectious prions and transmit the disease to subsequent surgical patients.

  • Incubation Period for Iatrogenic CJD: Ranges from $19\text{ to }46\text{ months}$ (and can extend up to several years).

  • Clinical Protocol: Diagnostic brain biopsy should be avoided if CJD is clinically suspected. If a biopsy is performed, all surgical instruments coming into contact with tissue must be completely destroyed/incinerated.

• Variant Creutzfeldt-Jakob Disease (vCJD):

  • First identified in $1996$ in Great Britain and European nations, linked directly to the consumption of beef contaminated with Bovine Spongiform Encephalopathy (BSE).

  • Affects a younger demographic compared to classical CJD.

  • Clinical Sequence: Initial presentation features severe psychiatric symptoms, psychosis, anxiety, and personality changes, followed weeks or months later by progressive cerebellar ataxia, myoclonus, and rapid dementia.

  • Blood Transfusion Risk: In December $2003$, the UK documented suspected vCJD transmission via blood transfusion from an asymptomatic donor who had donated blood $3.5\text{ years}$ ($42\text{ months}$) prior to clinical symptom onset.

• Chronic Wasting Disease (CWD):

  • Endemic among wild mule deer, elk, and moose populations in North American regions (including Colorado, Wyoming, and Montana).

  • Manifests as severe progressive weight loss, motor weakness, severe ataxia, and loss of fear toward humans.

  • Direct transmission to humans has not been definitively proven, but hunters are advised to avoid handling or consuming brain, spinal cord, or lymphatic tissues, and to avoid eating meat from visibly ill animals.

• Symptomatology and Late-Stage CJD:

  • Initial signs: Cerebellar ataxia, loss of motor coordination, unsteady gait, dysarthria, dysphagia, rigidity, and prominent myoclonus (rhythmic muscular jerking).

  • Progressive stage: Cognitive impairment, confusion, hallucinations, spatial disorientation, and severe affective psychosis.

  • Terminal stage: Complete mental incapacitation, profound muscle wasting, and akinetic mutism (a non-responsive vegetative state). Death occurs within $1\text{ year}$ of symptom onset for vCJD, and typically within $1\text{ to }2\text{ years}$ for classical CJD.

• Diagnostic Modalities:

  • Brain MRI: Shows distinct hyperintensity ("lighting up") localized to the basal ganglia and periventricular areas in approximately $80\%$ of affected patients.

  • EEG: Demonstrates characteristic periodic sharp wave complexes.

  • CSF Biomarkers: Elevated levels of specific proteins sent to reference laboratories (e.g., CDC).

  • Brain Biopsy: No longer advised due to instrument contamination risks.

Overview, Classification, and Differential Diagnosis of Encephalopathies

• General Definition:

  • Encephalopathy refers to generalized, widespread cortical cerebral dysfunction.

  • Onset can be acute (occurring within hours), subacute (days), or chronic.

• Clinical Characteristics:

  • Fluctuating levels of consciousness.

  • Severe impairment of attention span and inability to concentrate.

  • Frequent visual hallucinations, paranoia, and fixed delusions.

  • Alterations in psychomotor activity.

  • Electroencephalogram (EEG) consistently demonstrates generalized, diffuse background wave slowing.

• Delirium Parallel and Differential Diagnosis:

  • An acute encephalopathy presents clinically as delirium, defined as acute cognitive changes that cannot be fully explained by preexisting or evolving dementia.

  • Differential Diagnostic Mimics:

    • Dementia: Features a normal level of consciousness with far fewer acute hallucinations or delusions.

    • Acute Ischemic/Hemorrhagic Stroke: Causes focal neurological deficits and true language/aphasic abnormalities rather than global encephalopathy.

    • Postictal States: Transient confusion following a seizure.

    • Transient Ischemic Attack (TIA).

    • Normal Pressure Hydrocephalus (NPH): Presents with gait ataxia, urinary incontinence, and early cognitive decline.

Specific Encephalopathy Syndromes

• Hypertensive Encephalopathy (PRES): posterior reversible encephalopathy syndrome

  • Etiology: Acute, severe malignant hypertensive crisis. Common underlying triggers include acute glomerulonephritis, chronic renal failure, pheochromocytoma (renin-secreting tumors inducing extreme systemic vasoconstriction), sympathomimetic toxicity (cocaine), preeclampsia/eclampsia, or acute neuroinfections.

  • Clinical Manifestations: Progressive severe headaches, nausea, vomiting, acute visual disturbances, altered LOC, and papilledema on fundoscopic exam.

  • Diagnostic Imaging: Brain MRI demonstrates subtle focal cerebral edema predominantly restricted to the subcortical white and gray matter of the occipital lobes (termed

  • Management: Controlled reduction of blood pressure using continuous intravenous antihypertensives; prompt management renders symptoms fully reversible.

• Wernicke's Encephalopathy:

  • Etiology: Acute deficiency of thiamine (Vitamin $B_1$).

  • At-Risk Populations: Chronic alcoholism (impaired thiamine intestinal absorption and poor intake), severe malnutrition, prolonged starvation, bariatric surgical procedures involving intestinal bypass (malabsorption), HIV/AIDS, and end-stage renal disease (ESRD) on active hemodialysis (thiamine is water-soluble and cleared into dialysate).

  • Classic Triad of Wernicke's Encephalopathy:

    1. Confusion / acute altered LOC (inattention, apathy, agitation).

    2. Ataxia (broad-based, unsteady gait).

    3. Ophthalmoplegia / ocular motor dysfunction (nystagmus, lateral rectus muscle palsy, sluggish pupillary responses).

  • Additional Signs: Peripheral neuropathy, systemic hypotension, hypothermia, and lactic acidosis.

  • Diagnostic MRI: Hyperintensity and contrast enhancement specifically localized to the mammillary bodies and periaqueductal gray matter.

  • Treatment and Critical Warning:

    • Immediate IV administration of thiamine.

    • CRITICAL CLINICAL WARNING: Never administer high-concentration intravenous dextrose solutions (e.g., D50) prior to thiamine administration. Dextrose oxidation requires thiamine as a co-enzyme; giving dextrose alone rapidly drives remaining serum thiamine into cells, causing a catastrophic drop in circulating thiamine that precipitates irreversible brainstem and mammalian body necrosis. Hydration must be initiated with normal saline, and thiamine must precede dextrose.

  • Progression to Wernicke-Korsakoff Syndrome: Untreated Wernicke's encephalopathy transitions into an irreversible chronic state characterized by severe anterograde amnesia (total inability to form new memories or absorb new information), retrograde amnesia (loss of past memories), confabulation (fabricating memories to fill memory gaps), and chronic psychosis.

• Hypoxic-Ischemic Encephalopathy (HIE):

  • Etiology: Acute, global, profound reduction or total cessation of cerebral blood flow and oxygen delivery. Triggers include post-cardiopulmonary resuscitation (post-CPR), near-drowning, asphyxiation, strangulation, carbon monoxide poisoning, severe profound anemia (hemoglobin levels below $5\,g/dL$), and severe hypovolemic or septic shock.

  • Clinical Presentation: Deep comatose state, non-responsiveness, persistent generalized myoclonus (rhythmic muscular jerking), and early seizure activity (most prominent within the first $24\text{ hours}$).

  • Diagnostics: CT/MRI reveals severe diffuse cerebral edema. EEG demonstrates severe background slowing or non-convulsive status epilepticus.

  • Management:

    • Immediate airway protection and mechanical ventilation (for Glasgow Coma Scale $\le 8$).

    • Therapeutic Hypothermia (Targeted Temperature Management): Cooling the comatose patient to $32\text{ to }34^\circ\text{C}$ for a duration of $24\text{ to }48\text{ hours}$ post-cardiac arrest. Reduces cerebral metabolic rate of oxygen ($\text{CMRO}_2$), decreases ICP, and suppresses ischemia-reperfusion inflammation.

    • Anticonvulsant/Sedative Therapy: Administration of clonazepam (Klonopin) or propofol (Diprivan) to control continuous myoclonus and seizure discharges.

• Hepatic Encephalopathy:

  • Etiology: Advanced end-stage liver failure, cirrhosis, or portosystemic shunts (e.g., Transjugular Intrahepatic Portosystemic Shunts / TIPS) that bypass hepatic parenchymal clearance. Results in systemic accumulation of neurotoxins, primarily ammonia ($\text{NH}_3$).

  • Clinical Presentation: Personality changes, apathy, disinhibition, inversion of normal sleep-wake cycles (daytime somnolence and nighttime insomnia), progression to coma, and pathognomonic motor signs:

    • Asterixis: Involuntary, brief, flapping tremors of the hands when the arms are extended with wrists dorsiflexed ("liver flap").

    • Impaired Constructional Apraxia: Inability to draw basic intersecting figures (e.g., failure to connect lines when trying to draw a star).

  • Clinical Grading Scale (Grades 1 through 4):

    • Grade 1: Mild confusion, subtle personality changes, inversion of sleep cycles.

    • Grade 2: Lethargy, disorientation, presence of asterixis, and abnormal handwriting.

    • Grade 3: Somnolence, marked confusion, bizarre behavior, severe disorientation.

    • Grade 4: Coma (unresponsive to painful stimuli).

  • Diagnostic Nuance: Diagnosis is clinical and made by excluding other causes. Serum ammonia levels do not directly correlate with the clinical grade or severity of hepatic encephalopathy.

  • Treatment:

    • First-line pharmacological agent: Lactulose (a non-absorbable disaccharide). Acidifies the colon, trapping toxic ammonia ($\text{NH}_3$) as non-absorbable ammonium ($\text{NH}_4^+$), which is rapidly evacuated via osmotic diarrhea.

    • Lactulose Adverse Effects: Dehydration, hypernatremia, and severe perineal skin breakdown.

    • Secondary therapies: Oral non-absorbable antibiotics (e.g., Neomycin, Rifaximin) or probiotics to eliminate ammonia-producing colonic bacteria. Definitively cured only through liver transplantation.